Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amira Mira has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bio-guided discovery of antibacterial metabolites from Penicillium chrysogenum

    by Amira Mira, Fatma M. Abdel Bar, Ahmed I. Foudah, Mohamed H. Aboutaleb, Tarek S. Ibrahim, Ahmed H.E. Hassan, Ashraf T. Khalil

    Bio-guided isolation from the Red Sea-derived Penicillium chrysogenum yielded two new metabolites, 15-deoxy-15-amino-citreohybridonol (6) and chrysogenotoxin (7), alongside five known compounds: emodin (1), chrysophanol (2), bis(2-ethylhexyl) phthalate (3), haenamindole (4), and citreorosein (5). Compound 6 exhibited broad-spectrum antibacterial activity against both Gram-positive (MIC: 0.31-0.62 μM; MBC: 0.31-0.62 μM) and Gram-negative bacteria (MIC: 0.15-1.25 μM; MBC: 0.62-2.5 μM). Compound 7 showed potent bactericidal activity against Gram-negative bacteria (MIC: 0.07-0.31 μM; MBC: 0.15-0.62 μM) with MBC/MIC ≤ 4, while compound 4 selectively inhibited S. pneumoniae (MIC: 0.31 μM; MBC: 0.62 μM). Compounds 4, 6, and 7 exhibited low cytotoxicity towards human intestinal epithelial cells (HIEC-6). Molecular docking studies targeting the NDM-1 β-lactamase identified compounds 4, 6, and 7 as potential inhibitors of New Delhi metallo-β-lactamase-1 (NDM-1). Molecular dynamics simulations confirmed the structural stability of 7 within the NDM-1 active site. Chrysogenotoxin (7) was suggested as a promising antibacterial candidate against antibiotic-resistant pathogens.


  • In Vitro and In Silico Evaluation of Compounds from Washingtonia filifera as Acetylcholinesterase Inhibitors

    by Fatma Abdel Bar, Aalaa Salem, El-Sayed M. Marwan, Amal F. Soliman, Saleh H. El-Sharkawy, Amira Mira

    Nine known compounds were isolated from the fruitless bunches of Washingtonia filifera, an underutilized agricultural waste, using NMR and mass spectrometry. The identified compounds included β-sitosteryl oleate (1), oleic acid (2), β-sitosterol (3), threo-2,3-bis-(4-hydroxy-3-methoxyphenyl)-3-methoxypropanol (4), syringaresinol (5), diosmetin (6), tricin (7), daucosterol (8), and luteolin-7-O-β-Dglucoside (cynaroside) (9). In vitro acetylcholinesterase (AChE) inhibition assays revealed that compound 5 exhibited the strongest activity (IC50 = 29.75 μM), followed by compounds 4 and 6. Docking studies indicated significant interactions of the active compounds with key AChE residues, particularly Trp86 and Tyr341. ADME predictions further supported the drug-likeness of compounds 4 and 5. These results highlight the significance of W. filifera agricultural waste as a source of bioactive compounds, particularly with neuroprotective effects.

  • Open Access

    Antiparasitic and antimicrobial activity of Ipomoea palmata against Toxoplasma gondii and Staphylococcus aureus : correlation with major phenolics identified by HPLC

    by Amira Mira, Tariq M. Aljarba, Fatma M. Abdel Bar, Rehab Ahmed, Walaa A. Negm, Engy Elekhnawy, Hosam M. El-Seadawy, Eman A. Elmorsy, Salwa S. Younis

    Toxoplasma gondii, a protozoan parasite found in water sources, causes toxoplasmosis, with no current protocols for inactivating its oocysts in water. Staphylococcus aureus, a significant bacterial pathogen, is known for causing various illnesses, including skin infections and biofilm-related diseases. This study investigated the antibacterial and antiparasitic properties of Ipomoea palmata leaf extract, rich in phenolics, against T. gondii tachyzoites and S. aureus. I. palmata extract significantly reduced tachyzoites count in peritoneal fluids and liver smears of infected mice with alleviation of toxoplasmosis-induced hepatitis. SEM showed surface irregularities in tachyzoites from treated groups. The extract demonstrated antibacterial action against S. aureus with a minimum inhibitory concentration of 128 to 512 µg/mL, reduced biofilm formation from 69.23% to 15.38% of tested isolates, and downregulated biofilm genes (cna, fnbA, and ica) in 53.85% of isolates. Treatment with I. palmata extract improved liver architecture, reduced inflammation, and eliminated blood vessel congestion. The main phenolic acids identified by HPLC/UV analysis were chlorogenic acid, gallic acid, ellagic acid, and methyl gallate, while the predominant flavonoids were apigenin, quercetin, and naringenin. These findings highlight the potential of I. palmata extract as a natural antimicrobial and antiparasitic agent, warranting further research to isolate and evaluate its active compounds.


  • New neuroprotective derivatives of cinnamic acid by biotransformation

    by Hadeer Elkharsawy, Ramadan A. Eldomany, Amira Mira, Amal F. Soliman, Mohamed Amir, Saleh El-Sharkawy

    Microbial transformation is extensively utilized to generate new metabolites in bulk amounts with more specificity and improved activity.


  • Open Access

    In Vitro and In Silico Investigation of Polyacetylenes from Launaea capitata (Spreng.) Dandy as Potential COX-2, 5-LOX, and BchE Inhibitors

    by Fatma M. Abdel Bar, Amira Mira, Ahmed I. Foudah, Manal A. Alossaimi, Shatha F. Alkanhal, Alanoud M. Aldaej, Mai H. ElNaggar

    Diverse secondary metabolites are biosynthesized by plants via various enzymatic cascades. These have the capacity to interact with various human receptors, particularly enzymes implicated in the etiology of several diseases. The n-hexane fraction of the whole plant extract of the wild edible plant, Launaea capitata (Spreng.) Dandy was purified by column chromatography. Five polyacetylene derivatives were identified, including (3S,8E)-deca-8-en-4,6-diyne-1,3-diol (1A), (3S)-deca-4,6,8-triyne-1,3-diol (1B), (3S)-(6E,12E)-tetradecadiene-8,10-diyne-1,3-diol (2), bidensyneoside (3), and (3S)-(6E,12E)-tetradecadiene-8,10-diyne-1-ol-3-O-β-D-glucopyranoside (4). These compounds were investigated for their in vitro inhibitory activity against enzymes involved in neuroinflammatory disorders, including cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), and butyrylcholinesterase (BchE) enzymes. All isolates recorded weak–moderate activities against COX-2. However, the polyacetylene glycoside (4) showed dual inhibition against BchE (IC50 14.77 ± 1.55 μM) and 5-LOX (IC50 34.59 ± 4.26 μM). Molecular docking experiments were conducted to explain these results, which showed that compound 4 exhibited greater binding affinity to 5-LOX (−8.132 kcal/mol) compared to the cocrystallized ligand (−6.218 kcal/mol). Similarly, 4 showed a good binding affinity to BchE (−7.305 kcal/mol), which was comparable to the cocrystallized ligand (−8.049 kcal/mol). Simultaneous docking was used to study the combinatorial affinity of the unresolved mixture 1A/1B to the active sites of the tested enzymes. Generally, the individual molecules showed lower docking scores against all the investigated targets compared to their combination, which was consistent with the in vitro results. This study demonstrated that the presence of a sugar moiety (in 3 and 4) resulted in dual inhibition of 5-LOX and BchE enzymes compared to their free polyacetylenes analogs. Thus, polyacetylene glycosides could be suggested as potential leads for developing new inhibitors against the enzymes involved in neuroinflammation.